Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

What Quality Metrics Is My Hospital Being Evaluated on and What Are the Consequences?

Keswani A, Uhler LM, Bozic KJ.

J Arthroplasty. 2016 Jun;31(6):1139-43. doi: 10.1016/j.arth.2016.01.075.

PMID:
27101770
2.

Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.

Kessler J, Nucifora K, Li L, Uhler L, Braithwaite S.

Value Health. 2015 Dec;18(8):946-55. doi: 10.1016/j.jval.2015.09.2940.

3.

InformedTogether: Usability Evaluation of a Web-Based Decision Aid to Facilitate Shared Advance Care Planning for Severe Chronic Obstructive Pulmonary Disease.

Uhler LM, Pérez Figueroa RE, Dickson M, McCullagh L, Kushniruk A, Monkman H, Witteman HO, Hajizadeh N.

JMIR Hum Factors. 2015 Feb 25;2(1):e2. doi: 10.2196/humanfactors.3842.

4.

Understanding patients' and doctors' attitudes about shared decision making for advance care planning.

Hajizadeh N, Uhler LM, Pérez Figueroa RE.

Health Expect. 2015 Dec;18(6):2054-65. doi: 10.1111/hex.12285.

PMID:
25336141
5.

How inexpensive does an alcohol intervention in Kenya need to be in order to deliver favorable value by reducing HIV-related morbidity and mortality?

Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Li L, Mentor SM, Uhler LM, Roberts MS, Galvani A, Bryant K.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e54-8. doi: 10.1097/QAI.0000000000000140. No abstract available.

PMID:
24828269
6.

Identifying design considerations for a shared decision aid for use at the point of outpatient clinical care: An ethnographic study at an inner city clinic.

Hajizadeh N, Perez Figueroa RE, Uhler LM, Chiou E, Perchonok JE, Montague E.

J Particip Med. 2013 Mar 6;5. pii: e12.

7.

How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa?

Scott Braithwaite R, Nucifora KA, Toohey C, Kessler J, Uhler LM, Mentor SM, Keebler D, Hallett T.

AIDS. 2014 Jan;28 Suppl 1:S73-83. doi: 10.1097/QAD.0000000000000110.

8.

Impact of interventions targeting unhealthy alcohol use in Kenya on HIV transmission and AIDS-related deaths.

Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Mentor SM, Uhler LM, Roberts MS, Bryant K.

Alcohol Clin Exp Res. 2014 Apr;38(4):1059-67. doi: 10.1111/acer.12332.

9.

Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.

Anglaret X, Scott CA, Walensky RP, Ouattara E, Losina E, Moh R, Becker JE, Uhler L, Danel C, Messou E, Eholié S, Freedberg KA.

Antivir Ther. 2013;18(1):45-55. doi: 10.3851/IMP2231.

10.

The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.

Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RP.

PLoS One. 2012;7(4):e36001. doi: 10.1371/journal.pone.0036001.

11.

WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.

Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KA; CEPAC-International Investigators..

PLoS One. 2011;6(6):e20224. doi: 10.1371/journal.pone.0020224.

12.

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.

Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP; CEPAC-International and OCTANE Investigators..

AIDS. 2011 Feb 20;25(4):479-92. doi: 10.1097/QAD.0b013e3283428cbe.

13.

The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.

Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD; Cost-Effectiveness of Preventing AIDS Complications-International Investigators..

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):26-35. doi: 10.1097/QAI.0b013e3181fb8f24.

14.

Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.

Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, Swaminathan S; CEPAC International investigators..

PLoS One. 2010 Sep 16;5(9). pii: e12747. doi: 10.1371/journal.pone.0012747.

15.

The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.

Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, Ross D, Scott CA, Uhler LM, Katz JN, Holst H, Freedberg KA.

PLoS One. 2010 Mar 4;5(3):e9538. doi: 10.1371/journal.pone.0009538.

16.

Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.

Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, Ross D, Katz JN, Walensky RP, Freedberg KA, Losina E.

AIDS. 2010 Jan;24 Suppl 1:S37-44. doi: 10.1097/01.aids.0000366081.91192.1c.

17.

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA).; CEPAC International investigators..

PLoS Med. 2009 Oct;6(10):e1000173. doi: 10.1371/journal.pmed.1000173.

18.

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators..

Ann Intern Med. 2009 Aug 4;151(3):157-66.

19.

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.

Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA; CEPAC-International Investigators..

J Infect Dis. 2008 May 1;197(9):1324-32. doi: 10.1086/587184.

20.

Procedures for preparation of otological and audiological data for computer analysis.

White TP, Uhler LM Jr.

Laryngoscope. 1978 Nov;88(11):1836-45.

PMID:
713674
Items per page

Supplemental Content

Loading ...
Support Center